ONEMEDNET CORPORATION Convertible Notes Payable
ONEMEDNET CORPORATION (ONMD) had Convertible Notes Payable of $1.78 million as of 2024-03-31, per its 10-Q filed 2024-12-05.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:ConvertibleNotesPayable · last filed 2024-12-05
- 2024-03-31: Convertible Notes Payable $1.78M.
- 2023-12-31: Convertible Notes Payable $465.00K; Convertible Notes Payable as first filed $1.60M.
- 2023-09-30: Convertible Notes Payable $3.88M.
- 2022-12-31: Convertible Notes Payable $5.14M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2024-03-31 | $1.78M 10-Q · filed 2024-12-05 | |
| 2023-12-31 | $465.00K 10-Q · filed 2024-12-05 | $1.60M 10-K/A · filed 2024-11-05 |
| 2023-09-30 | $3.88M 10-Q · filed 2023-11-20 | |
| 2022-12-31 | $5.14M 10-K · filed 2024-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |